Company Filing History:
Years Active: 2025
Title: Elyse Bourque: Innovator in GPR84 Antagonists
Introduction
Elyse Bourque is a notable inventor based in L'Étang-du-Nord, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that target GPR84-mediated disorders. Her innovative work has led to the filing of one patent, showcasing her expertise and dedication to advancing medical science.
Latest Patents
Elyse Bourque holds a patent for "GPR84 antagonists and uses thereof." This invention provides compounds and compositions that inhibit GPR84, offering potential treatments for various disorders associated with this receptor. The implications of her work could lead to new therapeutic options for patients suffering from GPR84-mediated conditions.
Career Highlights
Elyse is currently employed at Liminal Biosciences Limited, where she collaborates with a team of skilled professionals. Her role involves research and development focused on innovative solutions in the biopharmaceutical sector. Her contributions have been instrumental in advancing the company's mission to improve health outcomes through scientific innovation.
Collaborations
Elyse Bourque works alongside talented colleagues, including Shaun Abbott and Mylène De Léséleuc. Their collaborative efforts enhance the research environment and foster the development of groundbreaking therapies.
Conclusion
Elyse Bourque is a pioneering inventor whose work on GPR84 antagonists holds promise for the treatment of various disorders. Her dedication to innovation and collaboration in the field of biochemistry continues to make a significant impact on medical research.